Pages that link to "Q28477257"

The following pages link to Episomal Viral cDNAs Identify a Reservoir That Fuels Viral Rebound after Treatment Interruption and That Contributes to Treatment Failure (Q28477257):

Displaying 43 items.

• Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus (Q26797870) (← links)
• Quantification of viral infection dynamics in animal experiments (Q26824804) (← links)
• Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes (Q28487524) (← links)
• Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring (Q30249830) (← links)
• Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers (Q33630471) (← links)
• High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay (Q33817708) (← links)
• Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy. (Q33936651) (← links)
• Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells (Q34059612) (← links)
• Incorporating alternative splicing and mRNA editing into the genetic analysis of complex traits. (Q34789256) (← links)
• HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles (Q35102172) (← links)
• The role of unintegrated DNA in HIV infection (Q35143730) (← links)
• Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth (Q35944804) (← links)
• Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy (Q36281833) (← links)
• Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs. (Q36311695) (← links)
• Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials (Q36408455) (← links)
• The role of HIV integration in viral persistence: no more whistling past the proviral graveyard (Q36515181) (← links)
• Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy. (Q36736667) (← links)
• Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation (Q36796554) (← links)
• Cell-associated HIV RNA: a dynamic biomarker of viral persistence (Q36798408) (← links)
• Modelling HIV-1 2-LTR dynamics following raltegravir intensification. (Q36904249) (← links)
• Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy (Q36950847) (← links)
• Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART. (Q37145779) (← links)
• How to best measure HIV reservoirs? (Q37149147) (← links)
• Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patients (Q37204137) (← links)
• An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate (Q37336473) (← links)
• Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification. (Q37621893) (← links)
• HIV-1 persistence in CD4+ T cells with stem cell-like properties (Q37646541) (← links)
• Potential Strategies for an HIV Infection Cure (Q37891583) (← links)
• HIV reservoirs and strategies for eradication (Q37976293) (← links)
• Eliminating the HIV reservoir (Q37993454) (← links)
• Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions (Q38246141) (← links)
• Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread (Q38851814) (← links)
• Preferential susceptibility of Th9 and Th2 CD4 T cells to X4-tropic HIV-1 infection (Q39326931) (← links)
• Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy (Q39525582) (← links)
• Accurate quantification of episomal HIV-1 two-long terminal repeat circles by use of optimized DNA isolation and droplet digital PCR. (Q40243427) (← links)
• The Use of Ultra-Sensitive Molecular Assays in HIV Cure-Related Research (Q42037424) (← links)
• Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy (Q44801683) (← links)
• Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control (Q58755453) (← links)
• How to escape treatment (Q59097007) (← links)
• Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy (Q90444562) (← links)
• A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up (Q91659679) (← links)
• Tat IRES modulator of tat mRNA (TIM-TAM): a conserved RNA structure that controls Tat expression and acts as a switch for HIV productive and latent infection (Q92240525) (← links)
• A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy (Q94587776) (← links)